Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

775 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intraoperative radiotherapy during radical prostatectomy for intermediate-risk to locally advanced prostate cancer: treatment technique and evaluation of perioperative and functional outcome vs standard radical prostatectomy, in a matched-pair analysis.
Rocco B, Jereczek-Fossa BA, Matei DV, Verweij F, Santoro L, Vavassori A, Ospina JC, Cedeira F, Ciocca M, Orecchia R, de Cobelli O. Rocco B, et al. Among authors: santoro l. BJU Int. 2009 Dec;104(11):1624-30. doi: 10.1111/j.1464-410X.2009.08668.x. Epub 2009 Jul 14. BJU Int. 2009. PMID: 19624597
Positive surgical margins after robotic assisted radical prostatectomy: a multi-institutional study.
Patel VR, Coelho RF, Rocco B, Orvieto M, Sivaraman A, Palmer KJ, Kameh D, Santoro L, Coughlin GD, Liss M, Jeong W, Malcolm J, Stern JM, Sharma S, Zorn KC, Shikanov S, Shalhav AL, Zagaja GP, Ahlering TE, Rha KH, Albala DM, Fabrizio MD, Lee DI, Chauhan S. Patel VR, et al. Among authors: santoro l. J Urol. 2011 Aug;186(2):511-6. doi: 10.1016/j.juro.2011.03.112. Epub 2011 Jun 15. J Urol. 2011. PMID: 21680001
Acute toxicity of image-guided hypofractionated radiotherapy for prostate cancer: nonrandomized comparison with conventional fractionation.
Jereczek-Fossa BA, Zerini D, Fodor C, Santoro L, Cambria R, Garibaldi C, Tagaste B, Vavassori A, Cattani F, Alterio D, Gherardi F, Serafini F, Rocco B, Musi G, De Cobelli O, Orecchia R. Jereczek-Fossa BA, et al. Among authors: santoro l. Urol Oncol. 2011 Sep-Oct;29(5):523-32. doi: 10.1016/j.urolonc.2009.10.004. Epub 2009 Dec 16. Urol Oncol. 2011. PMID: 20005749
Correlation between acute and late toxicity in 973 prostate cancer patients treated with three-dimensional conformal external beam radiotherapy.
Jereczek-Fossa BA, Zerini D, Fodor C, Santoro L, Serafini F, Cambria R, Vavassori A, Cattani F, Garibaldi C, Gherardi F, Ferrari A, Rocco B, Scardino E, de Cobelli O, Orecchia R. Jereczek-Fossa BA, et al. Among authors: santoro l. Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):26-34. doi: 10.1016/j.ijrobp.2009.07.1742. Epub 2010 Feb 3. Int J Radiat Oncol Biol Phys. 2010. PMID: 20133085
Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinoma.
Brookman-May S, May M, Zigeuner R, Shariat SF, Scherr DS, Chromecki T, Moch H, Wild PJ, Mohamad-Al-Ali B, Cindolo L, Wieland WF, Schips L, De Cobelli O, Rocco B, Santoro L, De Nunzio C, Tubaro A, Coman I, Feciche B, Truss M, Dalpiaz O, Hohenfellner M, Gilfrich C, Wirth MP, Burger M, Pahernik S; CORONA Project (Collaborative Research on Renal Neoplasms Association). Brookman-May S, et al. Among authors: santoro l. J Urol. 2011 Dec;186(6):2175-81. doi: 10.1016/j.juro.2011.07.105. Epub 2011 Oct 19. J Urol. 2011. PMID: 22014800
Image guided hypofractionated radiotherapy and quality of life for localized prostate cancer: prospective longitudinal study in 337 patients.
Jereczek-Fossa BA, Santoro L, Zerini D, Fodor C, Vischioni B, Dispinzieri M, Bossi-Zanetti I, Gherardi F, Bonora M, Caputo M, Vavassori A, Cambria R, Garibaldi C, Cattani F, Matei DV, Musi G, De Cobelli O, Orecchia R. Jereczek-Fossa BA, et al. Among authors: santoro l. J Urol. 2013 Jun;189(6):2099-103. doi: 10.1016/j.juro.2013.01.005. Epub 2013 Jan 9. J Urol. 2013. PMID: 23313200
Reporting combined outcomes with Trifecta and survival, continence, and potency (SCP) classification in 337 patients with prostate cancer treated with image-guided hypofractionated radiotherapy.
Jereczek-Fossa BA, Zerini D, Fodor C, Santoro L, Maucieri A, Gerardi MA, Vischioni B, Cambria R, Garibaldi C, Cattani F, Vavassori A, Matei DV, Musi G, De Cobelli O, Orecchia R. Jereczek-Fossa BA, et al. Among authors: santoro l. BJU Int. 2014 Dec;114(6b):E3-E10. doi: 10.1111/bju.12530. Epub 2014 Feb 14. BJU Int. 2014. PMID: 24712723
775 results